retatrutide: Retatrutide Vial of unapproved peptide retatrutide

The same limitations apply to oral tirzepatide drops

So far, most of the evidence comes from lab and tissue-sample studies rather than large human trials

(jofem.org) The best-case signal: modest weight loss in a shorter trial A frequently cited 12-week randomized trial result (as summarized in reviews) reported: ~2.6 kg average loss with AOD-9604 1 mg/day vs ~0.8 kg with placebo (PMC) This is the kind of result that can be statistically meaningful, clinically modest, and very sensitive to study design (diet, activity, baseline metabolic status, adherence)

[2] Lee SJ, McPherron AC

Find the best weight loss dietitian near you, covered by insurance